What is JB Hunt Trans's earnings per share (EPS)?

JB Hunt Trans (JBHT) reported diluted earnings per share of $6.12 for fiscal year 2025. This represents a 10.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

JB Hunt Trans Financials

JBHT

Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE December

This page shows JB Hunt Trans (JBHT) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 18 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI JBHT FY2025 2026-04-24

Cash generation is recovering faster than reported profit as capital intensity eases and the business runs with lean liquidity.

From FY2023 to FY2025, revenue slipped only 2.4%, but free cash flow swung from -$118M to $948M because capital spending fell from $1.86B to $731M while operating cash flow stayed near $1.7B. The key change is not a big sales rebound; it is that earlier expansion spending stopped absorbing most of the cash the network already produces.

FY2025 shows a tighter short-term liquidity posture than prior years, with just $17M of cash and a current ratio of 0.8x, yet long-term debt was cut to $767M from $1.33B in FY2023. That combination points to a company financing itself more through recurring cash generation and working-capital turnover than through a growing debt load.

The margin profile improved even without top-line help: operating margin rose to 7.2% in FY2025 from 6.9% in FY2024 while revenue was nearly flat, and SG&A fell from $306M to $282M. Management then directed almost the entire year’s free cash flow into buybacks of $923M, which means per-share results were helped by capital allocation as much as by operating recovery.

Financial Health Signals

Financial Profile 43/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of JB Hunt Trans's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

JB Hunt Trans has an operating margin of 7.2%, meaning the company retains $7 of operating profit per $100 of revenue. This results in a moderate score of 38/100, indicating healthy but not exceptional operating efficiency. This is up from 6.9% the prior year.

Growth

JB Hunt Trans's revenue declined 0.7% year-over-year, from $12.1B to $12.0B. This contraction results in a growth score of 28/100.

Leverage

JB Hunt Trans carries a low D/E ratio of 0.22, meaning only $0.22 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 98/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

JB Hunt Trans's current ratio of 0.83 is below the typical benchmark, resulting in a score of 11/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow

JB Hunt Trans has a free cash flow margin of 7.9%, earning a moderate score of 38/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

JB Hunt Trans's ROE of 16.8% shows moderate profitability relative to equity, earning a score of 47/100. This is up from 14.2% the prior year.

Altman Z-Score Safe

6.60

JB Hunt Trans scores 6.60, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($24.7B) relative to total liabilities ($4.4B). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Piotroski F-Score Strong

7/9

JB Hunt Trans passes 7 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed

2.81x

For every $1 of reported earnings, JB Hunt Trans generates $2.81 in operating cash flow ($1.7B OCF vs $598.3M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe

11.5x

JB Hunt Trans earns $11.5 in operating income for every $1 of interest expense ($865.1M vs $75.2M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$12.0B

YoY-0.7%

5Y CAGR+4.5%

10Y CAGR+6.8%

JB Hunt Trans generated $12.0B in revenue in fiscal year 2025. This represents a decrease of 0.7% from the prior year.

EBITDA

$1.6B

YoY-0.8%

5Y CAGR+5.0%

10Y CAGR+4.1%

JB Hunt Trans's EBITDA was $1.6B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 0.8% from the prior year.

Net Income

$598.3M

YoY+4.8%

5Y CAGR+3.4%

10Y CAGR+3.4%

JB Hunt Trans reported $598.3M in net income in fiscal year 2025. This represents an increase of 4.8% from the prior year.

EPS (Diluted)

$6.12

YoY+10.1%

5Y CAGR+5.2%

10Y CAGR+5.3%

JB Hunt Trans earned $6.12 per diluted share (EPS) in fiscal year 2025. This represents an increase of 10.1% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$947.6M

YoY+53.4%

5Y CAGR+19.8%

10Y CAGR+20.4%

JB Hunt Trans generated $947.6M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 53.4% from the prior year.

Cash & Debt

$17.3M

YoY-63.2%

5Y CAGR-44.0%

10Y CAGR+12.0%

JB Hunt Trans held $17.3M in cash against $766.9M in long-term debt as of fiscal year 2025.

Dividends Per Share

$0.44

YoY-74.4%

5Y CAGR-16.4%

10Y CAGR-6.3%

JB Hunt Trans paid $0.44 per share in dividends in fiscal year 2025. This represents a decrease of 74.4% from the prior year.

Shares Outstanding

95M

YoY-5.9%

5Y CAGR-2.2%

10Y CAGR-1.8%

JB Hunt Trans had 95M shares outstanding in fiscal year 2025. This represents a decrease of 5.9% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

7.2%

YoY+0.3pp

5Y CAGR-0.2pp

10Y CAGR-4.4pp

JB Hunt Trans's operating margin was 7.2% in fiscal year 2025, reflecting core business profitability. This is up 0.3 percentage points from the prior year.

Net Margin

5.0%

YoY+0.3pp

5Y CAGR-0.3pp

10Y CAGR-1.9pp

JB Hunt Trans's net profit margin was 5.0% in fiscal year 2025, showing the share of revenue converted to profit. This is up 0.3 percentage points from the prior year.

Return on Equity

16.8%

YoY+2.6pp

5Y CAGR-2.7pp

10Y CAGR-16.1pp

JB Hunt Trans's ROE was 16.8% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 2.6 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

$923.3M

YoY+79.7%

5Y CAGR+58.4%

10Y CAGR+13.4%

JB Hunt Trans spent $923.3M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 79.7% from the prior year.

Capital Expenditures

$730.7M

YoY-15.6%

5Y CAGR-0.2%

10Y CAGR+0.1%

JB Hunt Trans invested $730.7M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 15.6% from the prior year.

JBHT Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$12.0B-0.7%	$12.1B-5.8%	$12.8B-13.4%	$14.8B+21.7%	$12.2B+26.3%	$9.6B
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$281.5M-8.1%	$306.4M+11.6%	$274.6M+27.5%	$215.4M+10.1%	$195.6M+8.6%	$180.1M
Operating Income	$865.1M+4.1%	$831.2M-16.3%	$993.2M-25.4%	$1.3B+27.4%	$1.0B+46.6%	$713.1M
Interest Expense	$75.2M-4.8%	$79.0M+19.8%	$65.9M+28.7%	$51.2M+10.8%	$46.3M-2.8%	$47.6M
Income Tax	$195.8M+3.8%	$188.6M-8.7%	$206.6M-33.8%	$312.0M+30.6%	$239.0M+49.4%	$160.0M
Net Income	$598.3M+4.8%	$570.9M-21.6%	$728.3M-24.9%	$969.4M+27.4%	$760.8M+50.3%	$506.0M
EPS (Diluted)	$6.12+10.1%	$5.56-20.2%	$6.97-24.3%	$9.21+29.0%	$7.14+50.6%	$4.74

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	$3.1B-1.3%	$3.1B+1.4%	$3.1B+4.3%	$2.9B+0.2%	$2.9B-7.1%	$3.1B+2.5%	$3.1B+4.8%	$2.9B
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$61.9M-4.3%	$64.7M-6.3%	$69.0M-7.8%	$74.9M+2.6%	$73.0M-11.5%	$82.5M+13.9%	$72.4M-3.1%	$74.7M
Operating Income	$207.0M-16.0%	$246.5M+1.6%	$242.7M+23.0%	$197.3M+10.4%	$178.7M-13.7%	$207.0M-7.6%	$224.1M+8.9%	$205.7M
Interest Expense	$17.9M+2.6%	$17.5M-2.3%	$17.9M-16.0%	$21.3M+14.5%	$18.6M-17.1%	$22.4M+8.1%	$20.8M+2.7%	$20.2M
Income Tax	$47.6M-8.8%	$52.2M-3.2%	$53.9M+13.9%	$47.4M+11.9%	$42.3M+16.1%	$36.5M-28.9%	$51.3M+3.3%	$49.6M
Net Income	$141.6M-21.8%	$181.1M+6.0%	$170.8M+32.8%	$128.6M+9.2%	$117.7M-24.3%	$155.5M+2.2%	$152.1M+11.9%	$135.9M
EPS (Diluted)	$1.49	N/A	$1.76+34.4%	$1.31+12.0%	$1.17	N/A	$1.49+12.9%	$1.32

JBHT Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$7.9B-4.6%	$8.3B-3.2%	$8.6B+10.3%	$7.8B+14.6%	$6.8B+14.6%	$5.9B
Current Assets	$1.6B-9.4%	$1.8B-9.7%	$2.0B-11.3%	$2.2B-4.4%	$2.3B+25.6%	$1.8B
Cash & Equivalents	$17.3M-63.2%	$47.0M-11.9%	$53.3M+2.7%	$51.9M-85.4%	$355.5M+13.5%	$313.3M
Inventory	$42.2M+1.3%	$41.7M-1.2%	$42.2M+3.9%	$40.6M+62.2%	$25.0M+5.2%	$23.8M
Accounts Receivable	$1.2B-5.2%	$1.2B-8.3%	$1.3B-12.6%	$1.5B+1.4%	$1.5B+34.0%	$1.1B
Goodwill	$134.1M0.0%	$134.1M	N/A	N/A	$100.5M-4.6%	$105.4M
Total Liabilities	$4.4B+1.5%	$4.3B-4.2%	$4.5B+8.8%	$4.1B+12.1%	$3.7B+10.5%	$3.3B
Current Liabilities	$1.9B+15.3%	$1.7B+15.5%	$1.5B-7.4%	$1.6B-9.3%	$1.7B+59.4%	$1.1B
Long-Term Debt	$766.9M-21.6%	$977.7M-26.3%	$1.3B+5.1%	$1.3B+33.5%	$945.3M-27.6%	$1.3B
Total Equity	$3.6B-11.2%	$4.0B-2.2%	$4.1B+11.9%	$3.7B+17.6%	$3.1B+19.9%	$2.6B
Retained Earnings	$7.8B+5.8%	$7.4B+5.7%	$7.0B+8.6%	$6.4B+14.3%	$5.6B+12.8%	$5.0B

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$7.9B0.0%	$7.9B-2.2%	$8.1B-1.6%	$8.2B-0.2%	$8.3B-0.7%	$8.3B-0.2%	$8.3B-1.1%	$8.4B
Current Assets	$1.7B+7.1%	$1.6B-4.3%	$1.7B-0.6%	$1.7B+1.0%	$1.7B-5.7%	$1.8B-8.1%	$1.9B+0.7%	$1.9B
Cash & Equivalents	$4.6M-73.6%	$17.3M-66.9%	$52.3M+2.7%	$50.9M+17.3%	$43.4M-7.6%	$47.0M-60.8%	$120.0M+124.3%	$53.5M
Inventory	N/A	$42.2M	N/A	N/A	N/A	$41.7M	N/A	N/A
Accounts Receivable	$1.3B+14.4%	$1.2B-5.8%	$1.2B+4.2%	$1.2B-1.7%	$1.2B-1.7%	$1.2B-3.1%	$1.3B+0.9%	$1.3B
Goodwill	N/A	$134.1M	N/A	N/A	N/A	$134.1M	N/A	N/A
Total Liabilities	$4.3B-0.6%	$4.4B-3.8%	$4.5B-1.1%	$4.6B+4.5%	$4.4B+2.1%	$4.3B-0.6%	$4.3B-0.3%	$4.3B
Current Liabilities	$1.4B-29.5%	$1.9B+0.1%	$1.9B0.0%	$1.9B+3.1%	$1.9B+11.7%	$1.7B-17.8%	$2.0B+29.1%	$1.6B
Long-Term Debt	$1.3B+69.9%	$766.9M-15.0%	$902.2M-11.5%	$1.0B+15.9%	$880.2M-10.0%	$977.7M-5.3%	$1.0B-30.4%	$1.5B
Total Equity	$3.6B+0.8%	$3.6B-0.2%	$3.6B-2.3%	$3.7B-5.5%	$3.9B-3.7%	$4.0B+0.4%	$4.0B-1.9%	$4.1B
Retained Earnings	N/A	$7.8B	N/A	N/A	N/A	$7.4B	N/A	N/A

JBHT Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$1.7B+13.2%	$1.5B-15.0%	$1.7B-1.8%	$1.8B+45.2%	$1.2B+9.0%	$1.1B
Capital Expenditures	$730.7M-15.6%	$865.4M-53.5%	$1.9B+20.9%	$1.5B+62.6%	$947.6M+28.3%	$738.5M
Free Cash Flow	$947.6M+53.4%	$617.8M+624.4%	-$117.8M-149.9%	$236.1M-14.6%	$276.3M-28.1%	$384.3M
Investing Cash Flow	-$574.8M+13.4%	-$663.7M+60.6%	-$1.7B-8.7%	-$1.6B-76.7%	-$877.0M-43.1%	-$613.0M
Financing Cash Flow	-$1.1B-37.2%	-$825.8M-1324.2%	-$58.0M+89.1%	-$530.4M-74.1%	-$304.6M-31.5%	-$231.6M
Dividends Paid	$171.0M-2.6%	$175.5M+0.9%	$173.9M+4.3%	$166.7M+34.0%	$124.4M+8.9%	$114.2M
Share Buybacks	$923.3M+79.7%	$513.9M+222.1%	$159.6M-46.8%	$300.0M+97.8%	$151.7M+63.9%	$92.5M

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	$353.0M-8.4%	$385.6M-20.7%	$486.4M+21.0%	$402.1M-0.5%	$404.2M+27.3%	$317.6M-6.2%	$338.5M-6.1%	$360.6M
Capital Expenditures	$110.3M-17.9%	$134.3M+0.2%	$134.1M-38.1%	$216.5M-11.9%	$245.8M+9.6%	$224.3M+27.9%	$175.4M-33.1%	$262.3M
Free Cash Flow	$242.8M-3.4%	$251.3M-28.7%	$352.4M+89.9%	$185.6M+17.2%	$158.4M+69.7%	$93.3M-42.8%	$163.1M+66.0%	$98.2M
Investing Cash Flow	-$70.7M+15.7%	-$83.9M+8.7%	-$91.8M+47.2%	-$174.0M+22.7%	-$225.1M-20.9%	-$186.2M-157.0%	-$72.4M+70.1%	-$242.7M
Financing Cash Flow	-$295.0M+12.4%	-$336.7M+14.4%	-$393.2M-78.3%	-$220.5M-20.7%	-$182.7M+10.6%	-$204.5M-2.5%	-$199.6M-55.2%	-$128.6M
Dividends Paid	$42.6M+1.7%	$41.9M-1.5%	$42.5M-0.3%	$42.6M-3.1%	$44.0M+1.3%	$43.4M-0.6%	$43.7M-0.7%	$44.0M
Share Buybacks	$80.1M-42.8%	$139.9M-39.3%	$230.4M-27.7%	$318.8M+36.2%	$234.1M+173.4%	$85.6M-57.2%	$200.0M-1.5%	$203.1M

JBHT Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	7.2%+0.3pp	6.9%-0.9pp	7.7%-1.2pp	9.0%+0.4pp	8.6%+1.2pp	7.4%
Net Margin	5.0%+0.3pp	4.7%-1.0pp	5.7%-0.9pp	6.5%+0.3pp	6.3%+1.0pp	5.3%
Return on Equity	16.8%+2.6pp	14.2%-3.5pp	17.8%-8.7pp	26.4%+2.0pp	24.4%+4.9pp	19.5%
Return on Assets	7.5%+0.7pp	6.9%-1.6pp	8.5%-4.0pp	12.4%+1.2pp	11.2%+2.7pp	8.5%
Current Ratio	0.83-0.2	1.06-0.3	1.35-0.1	1.41+0.1	1.34-0.4	1.70
Debt-to-Equity	0.22-0.0	0.24-0.1	0.32-0.0	0.34+0.0	0.30-0.2	0.50
FCF Margin	7.9%+2.8pp	5.1%+6.0pp	-0.9%-2.5pp	1.6%-0.7pp	2.3%-1.7pp	4.0%

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	6.8%-1.2pp	8.0%+0.0pp	8.0%+1.2pp	6.7%+0.6pp	6.1%-0.5pp	6.6%-0.7pp	7.3%+0.3pp	7.0%
Net Margin	4.6%-1.2pp	5.9%+0.3pp	5.6%+1.2pp	4.4%+0.4pp	4.0%-0.9pp	4.9%-0.0pp	5.0%+0.3pp	4.6%
Return on Equity	3.9%-1.1pp	5.1%+0.3pp	4.8%+1.3pp	3.5%+0.5pp	3.0%-0.8pp	3.9%+0.1pp	3.8%+0.5pp	3.3%
Return on Assets	1.8%-0.5pp	2.3%+0.2pp	2.1%+0.6pp	1.6%+0.1pp	1.4%-0.4pp	1.9%+0.0pp	1.8%+0.2pp	1.6%
Current Ratio	1.26+0.4	0.83-0.0	0.870.0	0.87-0.0	0.89-0.2	1.06+0.1	0.94-0.3	1.21
Debt-to-Equity	0.36+0.1	0.22-0.0	0.25-0.0	0.28+0.1	0.23-0.0	0.24-0.0	0.26-0.1	0.36
FCF Margin	7.9%-0.2pp	8.1%-3.4pp	11.5%+5.2pp	6.3%+0.9pp	5.4%+2.4pp	3.0%-2.3pp	5.3%+2.0pp	3.4%

Note: The current ratio is below 1.0 (0.83), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

C H Robinson Worldwide Inc CHRW

$18.8B

$20.1B

$18.3B

$90.7B

$83.7B

Frequently Asked Questions

What is JB Hunt Trans's annual revenue?

JB Hunt Trans (JBHT) reported $12.0B in total revenue for fiscal year 2025. This represents a -0.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is JB Hunt Trans's revenue growing?

JB Hunt Trans (JBHT) revenue declined by 0.7% year-over-year, from $12.1B to $12.0B in fiscal year 2025.

Is JB Hunt Trans profitable?

Yes, JB Hunt Trans (JBHT) reported a net income of $598.3M in fiscal year 2025, with a net profit margin of 5.0%.

What is JB Hunt Trans's EBITDA?

JB Hunt Trans (JBHT) had EBITDA of $1.6B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does JB Hunt Trans have?

As of fiscal year 2025, JB Hunt Trans (JBHT) had $17.3M in cash and equivalents against $766.9M in long-term debt.

What is JB Hunt Trans's operating margin?

JB Hunt Trans (JBHT) had an operating margin of 7.2% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is JB Hunt Trans's net profit margin?

JB Hunt Trans (JBHT) had a net profit margin of 5.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does JB Hunt Trans pay dividends?

Yes, JB Hunt Trans (JBHT) paid $0.44 per share in dividends during fiscal year 2025.

What is JB Hunt Trans's return on equity (ROE)?

JB Hunt Trans (JBHT) has a return on equity of 16.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is JB Hunt Trans's free cash flow?

JB Hunt Trans (JBHT) generated $947.6M in free cash flow during fiscal year 2025. This represents a 53.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is JB Hunt Trans's operating cash flow?

JB Hunt Trans (JBHT) generated $1.7B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are JB Hunt Trans's total assets?

JB Hunt Trans (JBHT) had $7.9B in total assets as of fiscal year 2025, including both current and long-term assets.

What are JB Hunt Trans's capital expenditures?

JB Hunt Trans (JBHT) invested $730.7M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Does JB Hunt Trans buy back shares?

Yes, JB Hunt Trans (JBHT) spent $923.3M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does JB Hunt Trans have outstanding?

JB Hunt Trans (JBHT) had 95M shares outstanding as of fiscal year 2025.

What is JB Hunt Trans's current ratio?

JB Hunt Trans (JBHT) had a current ratio of 0.83 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is JB Hunt Trans's debt-to-equity ratio?

JB Hunt Trans (JBHT) had a debt-to-equity ratio of 0.22 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is JB Hunt Trans's return on assets (ROA)?

JB Hunt Trans (JBHT) had a return on assets of 7.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is JB Hunt Trans's Altman Z-Score?

JB Hunt Trans (JBHT) has an Altman Z-Score of 6.60, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is JB Hunt Trans's Piotroski F-Score?

JB Hunt Trans (JBHT) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are JB Hunt Trans's earnings high quality?

JB Hunt Trans (JBHT) has an earnings quality ratio of 2.81x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can JB Hunt Trans cover its interest payments?

JB Hunt Trans (JBHT) has an interest coverage ratio of 11.5x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is JB Hunt Trans?

JB Hunt Trans (JBHT) scores 43 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.